Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD

Saved in:

Bibliographic Details
Published in:	Bone marrow transplantation (Basingstoke) Vol. 45; no. 1; pp. 205 - 207
Main Authors:	Rodriguez, R, Nademanee, A, Palmer, J M, Parker, P, Nakamura, R, Snyder, D, Pullarkat, V, Zain, J, Smith, E, Sahebi, F, Patane, K, Senitzer, D, Chang, K, Forman, S J
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-01-2010 Nature Publishing Group
Subjects:	Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibodies, Monoclonal - therapeutic use Antilymphocyte Serum Biological and medical sciences Bone marrow, stem cells transplantation. Graft versus host reaction Cell Biology Cyclosporine - therapeutic use Diagnosis Drug therapy Female Graft versus host reaction Graft vs Host Disease - prevention & control Hematology Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic stem cells Humans Internal Medicine letter-to-the-editor Male Medical sciences Medicine Medicine & Public Health Middle Aged Mycophenolic Acid - analogs & derivatives Public Health Risk factors Stem cell transplantation Stem Cells Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation United States Immunopathology Graft versus host disease Hematology Enzyme Unrelated donor Stem cell Intensity IMP dehydrogenase Enzyme inhibitor Hematopoietic cell Homograft Immunomodulator Prevention Chronic Graft Oxidoreductases Immunosuppressive agent Mycophenolate mofetil Antithymocyte globulin
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Other Sources-1 ObjectType-Article-2 content type line 63 ObjectType-Feature-1 ObjectType-Correspondence-3
ISSN:	0268-3369 1476-5365
DOI:	10.1038/bmt.2009.112